The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion.
about
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) familyThe urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferiSingle amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasionMembrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells.Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonistsRelevance of novel inflammatory markers in stroke-induced immunosuppressionBiomarkers of kidney injury and klotho in patients with atherosclerotic renovascular disease.Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.The many spaces of uPAR: delivery of theranostic agents and nanobins to multiple tumor compartments through a single targetHas the circulating permeability factor in primary FSGS been found?Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells.The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability.Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic.The plasminogen system in regulating stem cell mobilization.Serum suPAR in patients with FSGS: trash or treasure?The urokinase receptor takes control of cell migration by recruiting integrins and FPR1 on the cell surfaceThe cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.Role of formic receptors in soluble urokinase receptor-induced human vascular smooth muscle migration.An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment.Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients.The intriguing role of soluble urokinase receptor in inflammatory diseases.Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury.Interleukin-6 Infusion During Human Endotoxaemia Inhibits In Vitro Release of the Urokinase Receptor from Peripheral Blood Mononuclear CellsPlasma Levels of Intact and Cleaved Urokinase Receptor Decrease in HIV-1-Infected Patients Initiating Highly Active Antiretroviral TherapyTreatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage PolarizationThe urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation
P2860
Q24652940-6ED2372D-DE5C-41AB-9636-E6EC5DDFAC0CQ27316838-62E00433-B2A1-402B-8864-301DC1D42BA5Q27319474-D45E5D6B-E596-4238-BB69-D07B6F532ABCQ30486721-BFCFF0C9-B7E4-4736-ABB0-84BCA6A480F7Q31038443-C80B8235-FED3-4C23-B584-EEC40999EA35Q34645842-4778C667-3F0D-4993-9374-EBF218B64F4AQ35111792-34B3A63E-1B9E-48E3-BD25-9E7805C83945Q35144440-F15796C4-0153-4F74-B0C2-ECAEE9333DDDQ35621562-26BB4C34-E42E-4615-8755-41162EC4AD7BQ36997621-F9807D38-30C4-4754-B83C-7F2A26189B06Q37070274-7CA14414-9825-4026-94AA-7D57C423DEE4Q37087120-90648D6D-EB40-4C03-BF04-00DD944079ADQ37285095-3FE4FB41-D330-4845-B1A3-FFE9C244C783Q37286882-73068839-4B67-4B94-AD60-A8A82412BA3AQ37895294-33BC834D-25D2-47E1-BDD6-8ADA864FA9F8Q38057219-8F9197F7-F08C-49A5-B285-951108643DCFQ38091638-6E0C9197-7EC2-4C4F-830F-525D4412FEC8Q39030266-FD33B923-677B-4BA8-A2D0-C83B7723C9D4Q39640346-5CF9F675-DED7-4A3D-A3D2-822306305CE7Q40186402-D0EC29A4-D80D-4A4E-9B9D-1BB3CABFD998Q40355156-4FC391E1-2E44-4B8A-A53E-FA01A7BC3D91Q40428098-412ECBFC-2692-4E2F-A0B7-47D3F5D366B4Q41761236-BEFE6C10-C97E-4F09-818E-F691DB1CBFDCQ45474248-DA57B984-2965-4AF3-83AC-A10B15EA8DD5Q49124480-F044E70A-9414-485D-BF0A-CD54FD1B54B0Q54988971-149CB962-4A90-4D52-8953-43F95600FC1BQ56240277-78DC7C1C-0FDD-4D8E-A9B9-AB7E07CB6C7AQ57609583-2BC43338-9F7D-474A-A5C3-DA263F556B49Q58883590-A872B7D0-488D-4158-8416-5D49D47AC10CQ58883591-03E95B14-0AEA-473B-8CDA-6A51ED6F9C4C
P2860
The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The soluble D2D3
@nl
The soluble D2D3(88-274) fragm ...... egrin-dependent cell adhesion.
@en
type
label
The soluble D2D3
@nl
The soluble D2D3(88-274) fragm ...... egrin-dependent cell adhesion.
@en
prefLabel
The soluble D2D3
@nl
The soluble D2D3(88-274) fragm ...... egrin-dependent cell adhesion.
@en
P2093
P356
P1476
The soluble D2D3(88-274) fragm ...... egrin-dependent cell adhesion.
@en
P2093
Carlo Laudanna
Federico Furlan
Francesco Blasi
Massimo Resnati
Simone Orlando
Veronica Basso
P304
P356
10.1242/JCS.01149
P407
P50
P577
2004-06-01T00:00:00Z